These results, in combination with the non-cytotoxic acute effect of this natural bioactive and the potentiated glucose-induced insulin secretion in human pseudo-islets, indicate that the dietary intake of kaempferol may be developed as an adjuvant to support existing therapies for the treatment of diabetes. This evidence concerns the gene INS and diabetes mellitus.